NASDAQ:HTGM

HTG Molecular Diagnostics News Headlines

$4.38
-0.14 (-3.10 %)
(As of 04/16/2021 04:00 PM ET)
Add
Compare
Today's Range
$4.30
Now: $4.38
$4.60
50-Day Range
$4.52
MA: $5.65
$6.34
52-Week Range
$3.78
Now: $4.38
$13.80
Volume50,352 shs
Average Volume162,027 shs
Market Capitalization$27.22 million
P/E RatioN/A
Dividend YieldN/A
Beta1.63

Headlines

HTG Molecular Diagnostics (NASDAQ HTGM) News Headlines Today

SourceHeadline
HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Sees Significant Growth in Short InterestHTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Sees Significant Growth in Short Interest
americanbankingnews.com - April 17 at 8:32 AM
HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Expected to Announce Quarterly Sales of $2.00 MillionHTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Expected to Announce Quarterly Sales of $2.00 Million
americanbankingnews.com - April 7 at 1:26 AM
HTG Molecular Drops Over 7% As 1Q Revenue Forecast Lags EstimatesHTG Molecular Drops Over 7% As 1Q Revenue Forecast Lags Estimates
finance.yahoo.com - April 6 at 1:15 PM
Zacks: Analysts Expect HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) to Announce -$0.92 Earnings Per ShareZacks: Analysts Expect HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) to Announce -$0.92 Earnings Per Share
americanbankingnews.com - April 5 at 10:06 PM
HTG Molecular Diagnostics Reports Preliminary First Quarter 2021 Financial ResultsHTG Molecular Diagnostics Reports Preliminary First Quarter 2021 Financial Results
finance.yahoo.com - April 5 at 7:18 PM
Equities Analysts Set Expectations for HTG Molecular Diagnostics, Inc.s Q1 2022 Earnings (NASDAQ:HTGM)Equities Analysts Set Expectations for HTG Molecular Diagnostics, Inc.'s Q1 2022 Earnings (NASDAQ:HTGM)
americanbankingnews.com - March 31 at 2:42 AM
SVB Leerink Comments on HTG Molecular Diagnostics, Inc.s Q1 2022 Earnings (NASDAQ:HTGM)SVB Leerink Comments on HTG Molecular Diagnostics, Inc.'s Q1 2022 Earnings (NASDAQ:HTGM)
americanbankingnews.com - March 29 at 2:36 AM
HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Short Interest UpdateHTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Short Interest Update
americanbankingnews.com - March 28 at 5:50 PM
HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q4 2020 Results - Earnings Call TranscriptHTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - March 27 at 10:41 PM
Analyst Forecasts Just Became More Bearish On HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM)Analyst Forecasts Just Became More Bearish On HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM)
nasdaq.com - March 26 at 8:47 PM
HTG Molecular Diagnostics (NASDAQ:HTGM) Announces  Earnings Results, Beats Estimates By $0.17 EPSHTG Molecular Diagnostics (NASDAQ:HTGM) Announces Earnings Results, Beats Estimates By $0.17 EPS
americanbankingnews.com - March 26 at 10:42 AM
HTG Molecular Diagnostics (NASDAQ:HTGM) Rating Reiterated by HC WainwrightHTG Molecular Diagnostics (NASDAQ:HTGM) Rating Reiterated by HC Wainwright
americanbankingnews.com - March 26 at 8:14 AM
HTG Molecular Diagnostics Reports Full Year 2020 ResultsHTG Molecular Diagnostics Reports Full Year 2020 Results
finance.yahoo.com - March 25 at 7:39 PM
HTG Molecular Diagnostics to Announce Year End 2020 Financial Results and Host Conference Call on Thursday, March 25HTG Molecular Diagnostics to Announce Year End 2020 Financial Results and Host Conference Call on Thursday, March 25
finance.yahoo.com - March 16 at 7:59 PM
HTG Concludes Feasibility Testing & Releases Second White Paper for its Planned Whole Transcriptome Panel Using HTG EdgeSeq TechnologyHTG Concludes Feasibility Testing & Releases Second White Paper for its Planned Whole Transcriptome Panel Using HTG EdgeSeq Technology
finance.yahoo.com - February 26 at 12:59 PM
HTG Announces Board of Directors TransitionHTG Announces Board of Directors Transition
finance.yahoo.com - January 19 at 6:20 PM
HTG Molecular Diagnostics Announces Certain Preliminary 2020 Unaudited Financial ResultsHTG Molecular Diagnostics Announces Certain Preliminary 2020 Unaudited Financial Results
finance.yahoo.com - January 5 at 9:17 AM
HTG Expands Patent Portfolio with New Canadian Patent for its Nuclease Protection Methods for Detection of Nucleotide VariantsHTG Expands Patent Portfolio with New Canadian Patent for its Nuclease Protection Methods for Detection of Nucleotide Variants
finance.yahoo.com - December 30 at 10:13 AM
HTG Announces First Collaborator in Early Access Program for its Prototype Whole Transcriptome PanelHTG Announces First Collaborator in Early Access Program for its Prototype Whole Transcriptome Panel
finance.yahoo.com - December 18 at 8:09 AM
HTG Announces an Early Access Program for its Prototype Whole Transcriptome PanelHTG Announces an Early Access Program for its Prototype Whole Transcriptome Panel
finance.yahoo.com - December 8 at 8:18 PM
News for HTG Molecular Diagnostics IncNews for HTG Molecular Diagnostics Inc
markets.businessinsider.com - November 30 at 10:32 PM
HTG Molecular Diagnostics announced 1:15 reverse stock splitHTG Molecular Diagnostics announced 1:15 reverse stock split
seekingalpha.com - November 23 at 2:43 PM
HTG Announces One-for-Fifteen Reverse Stock SplitHTG Announces One-for-Fifteen Reverse Stock Split
finance.yahoo.com - November 23 at 8:28 AM
HTG Molecular Diagnostics (HTGM) Investor Presentation - SlideshowHTG Molecular Diagnostics (HTGM) Investor Presentation - Slideshow
seekingalpha.com - November 19 at 5:58 PM
Newsflash: HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Analysts Have Been Trimming Their Revenue ForecastsNewsflash: HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Analysts Have Been Trimming Their Revenue Forecasts
finance.yahoo.com - November 15 at 12:56 PM
HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q3 2020 Results - Earnings Call TranscriptHTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 11 at 8:06 AM
HTG Molecular EPS beats by $0.01, misses on revenueHTG Molecular EPS beats by $0.01, misses on revenue
seekingalpha.com - November 10 at 8:32 PM
HTG Molecular Diagnostics Reports Third Quarter 2020 ResultsHTG Molecular Diagnostics Reports Third Quarter 2020 Results
finance.yahoo.com - November 10 at 8:32 PM
HTG Molecular Diagnostics: Q3 Earnings InsightsHTG Molecular Diagnostics: Q3 Earnings Insights
finance.yahoo.com - November 10 at 8:32 PM
Earnings Preview for HTG Molecular DiagnosticsEarnings Preview for HTG Molecular Diagnostics
finance.yahoo.com - November 9 at 1:54 PM
HTG Demonstrates Technical Feasibility for a Whole Transcriptome Panel Using HTG EdgeSeq TechnologyHTG Demonstrates Technical Feasibility for a Whole Transcriptome Panel Using HTG EdgeSeq Technology
finance.yahoo.com - November 2 at 6:33 PM
HTG Molecular Diagnostics to Announce Third Quarter 2020 Financial Results and Host Conference Call on Tuesday, November 10HTG Molecular Diagnostics to Announce Third Quarter 2020 Financial Results and Host Conference Call on Tuesday, November 10
finance.yahoo.com - October 30 at 8:27 AM
HTG Molecular Diagnostics, Inc. Common Stock (HTGM)HTG Molecular Diagnostics, Inc. Common Stock (HTGM)
nasdaq.com - October 23 at 8:35 PM
HTG Molecular Diagnostics to Present Corporate Overview at Fall Investor ConferencesHTG Molecular Diagnostics to Present Corporate Overview at Fall Investor Conferences
finance.yahoo.com - September 8 at 6:51 PM
Global MicroRNA Reverse Transcription Market 2020 Regional Production Volume, Business Operation Data Analysis, Revenue and Growth Rate by 2025Global MicroRNA Reverse Transcription Market 2020 Regional Production Volume, Business Operation Data Analysis, Revenue and Growth Rate by 2025
marketwatch.com - September 4 at 9:13 PM
HTG Introduces Oncology Applications and Expands Analytics Capabilities with Release of New Software UpdateHTG Introduces Oncology Applications and Expands Analytics Capabilities with Release of New Software Update
finance.yahoo.com - August 18 at 1:19 PM
HTG Molecular Provides Update on Patent Infringement Claims Against BioSpyderHTG Molecular Provides Update on Patent Infringement Claims Against BioSpyder
finance.yahoo.com - August 14 at 7:11 PM
More on HTG Molecular Q2 earningsMore on HTG Molecular Q2 earnings
seekingalpha.com - August 12 at 8:03 PM
HTG Molecular Diagnostics Reports Second Quarter 2020 ResultsHTG Molecular Diagnostics Reports Second Quarter 2020 Results
finance.yahoo.com - August 11 at 11:59 PM
HTG Molecular Diagnostics (HTGM) CEO John Lubniewski on Q2 2020 Results - Earnings Call TranscriptHTG Molecular Diagnostics' (HTGM) CEO John Lubniewski on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 11 at 11:59 PM
HTG Molecular Diagnostics: Q2 Earnings InsightsHTG Molecular Diagnostics: Q2 Earnings Insights
finance.yahoo.com - August 11 at 11:59 PM
HTG Molecular EPS in-line, beats on revenueHTG Molecular EPS in-line, beats on revenue
seekingalpha.com - August 11 at 6:59 PM
HTG Molecular inks deal with Qiagen for CDx programsHTG Molecular inks deal with Qiagen for CDx programs
seekingalpha.com - August 11 at 1:57 PM
HTG Molecular Diagnostics Announces New Commercialization and Distribution Agreement for Companion Diagnostics with QIAGENHTG Molecular Diagnostics Announces New Commercialization and Distribution Agreement for Companion Diagnostics with QIAGEN
finance.yahoo.com - August 10 at 5:52 PM
Earnings Preview: HTG Molecular DiagnosticsEarnings Preview: HTG Molecular Diagnostics
benzinga.com - August 10 at 12:51 PM
HTG Molecular Diagnostics to Announce Second Quarter 2020 Financial Results and Host Conference Call on Tuesday, August 11HTG Molecular Diagnostics to Announce Second Quarter 2020 Financial Results and Host Conference Call on Tuesday, August 11
finance.yahoo.com - August 5 at 5:29 PM
HTG Introduces HTG EdgeSeq Reveal RUO Oncology ApplicationsHTG Introduces HTG EdgeSeq Reveal RUO Oncology Applications
finance.yahoo.com - August 4 at 9:51 AM
HTG Expands RUO Profiling Menu with New NGS Platform Capability AssaysHTG Expands RUO Profiling Menu with New NGS Platform Capability Assays
finance.yahoo.com - July 30 at 5:55 PM
HTG Launches New HTG EdgeSeq Pan B-Cell Lymphoma PanelHTG Launches New HTG EdgeSeq Pan B-Cell Lymphoma Panel
finance.yahoo.com - July 28 at 6:21 PM
Will HTG Molecular Diagnostics, Inc. (HTGM) Report Negative Q2 Earnings? What You Should KnowWill HTG Molecular Diagnostics, Inc. (HTGM) Report Negative Q2 Earnings? What You Should Know
finance.yahoo.com - July 28 at 1:20 PM
This page was last updated on 4/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.